These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8595091)
41. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. Ioanoviciu A; Antony S; Pommier Y; Staker BL; Stewart L; Cushman M J Med Chem; 2005 Jul; 48(15):4803-14. PubMed ID: 16033260 [TBL] [Abstract][Full Text] [Related]
42. A class of novel N-isoquinoline-3-carbonyl-L-amino acid benzylesters: synthesis, anti-tumor evaluation and 3D QSAR analysis. Zheng M; Yang Y; Zhao M; Zhang X; Wu J; Chen G; Peng L; Wang Y; Peng S Eur J Med Chem; 2011 May; 46(5):1672-81. PubMed ID: 21414693 [TBL] [Abstract][Full Text] [Related]
43. Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4. Tsou HR; Liu X; Birnberg G; Kaplan J; Otteng M; Tran T; Kutterer K; Tang Z; Suayan R; Zask A; Ravi M; Bretz A; Grillo M; McGinnis JP; Rabindran SK; Ayral-Kaloustian S; Mansour TS J Med Chem; 2009 Apr; 52(8):2289-310. PubMed ID: 19317452 [TBL] [Abstract][Full Text] [Related]
44. 5,6-Dihydropyrrolo[2,1-a]isoquinolines as Alternative of New Drugs with Cytotoxic Activity. Chávez-Santos RM; Reyes-Gutiérrez PE; Torres-Ochoa RO; Ramírez-Apan MT; Martínez R Chem Pharm Bull (Tokyo); 2017 Oct; 65(10):973-981. PubMed ID: 28740026 [TBL] [Abstract][Full Text] [Related]
45. The cytotoxic activity of cyclic imido alkyl ethers, thioethers, sulfoxides, sulfones and related derivatives. Hall IH; Chapman JM; Wong OT Anticancer Drugs; 1994 Feb; 5(1):75-82. PubMed ID: 8186434 [TBL] [Abstract][Full Text] [Related]
46. Qualitative and quantitative determination of two new antitumor agents from 1-8 naphthalimides in tablets. Validation of a high performance liquid chromatography method. Camacho MA; Torres AI; Gil ME; Obregón MM; Ruz V Arzneimittelforschung; 1994 May; 44(5):659-62. PubMed ID: 8024643 [TBL] [Abstract][Full Text] [Related]
47. Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model. Jayaraman M; Fox BM; Hollingshead M; Kohlhagen G; Pommier Y; Cushman M J Med Chem; 2002 Jan; 45(1):242-9. PubMed ID: 11754595 [TBL] [Abstract][Full Text] [Related]
48. 4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4). Tsou HR; Otteng M; Tran T; Floyd MB; Reich M; Birnberg G; Kutterer K; Ayral-Kaloustian S; Ravi M; Nilakantan R; Grillo M; McGinnis JP; Rabindran SK J Med Chem; 2008 Jun; 51(12):3507-25. PubMed ID: 18494457 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents. Cho WJ; Park MJ; Chung BH; Lee CO Bioorg Med Chem Lett; 1998 Jan; 8(1):41-6. PubMed ID: 9871625 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones. Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Luzikov YN; Buyanov VN; Treshalina HM; Lesnaya NA; Romanenko VI; Kaluzhny DN; Balzarini J; Agama K; Pommier Y; Shtil AA; Preobrazhenskaya MN Eur J Med Chem; 2014 Oct; 86():797-805. PubMed ID: 25244612 [TBL] [Abstract][Full Text] [Related]
51. Nonhematotoxic naphthalene diimide modified by polyamine: synthesis and biological evaluation. Wang Y; Zhang X; Zhao J; Xie S; Wang C J Med Chem; 2012 Apr; 55(7):3502-12. PubMed ID: 22428910 [TBL] [Abstract][Full Text] [Related]
52. Antitumor efficacy and apoptotic activity of substituted chloroalkyl 1H-benz[de]isoquinoline-1,3-diones: a new class of potential antineoplastic agents. Mukherjee A; Hazra S; Dutta S; Muthiah S; Mondhe DM; Sharma PR; Singh SK; Saxena AK; Qazi GN; Sanyal U Invest New Drugs; 2011 Jun; 29(3):434-42. PubMed ID: 20066471 [TBL] [Abstract][Full Text] [Related]
53. Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study. Abdel-Aziz AA Eur J Med Chem; 2007 May; 42(5):614-26. PubMed ID: 17234303 [TBL] [Abstract][Full Text] [Related]
54. Apoptotic events induced by maleimides on human acute leukemia cell lines. Machado KE; de Oliveira KN; Andreossi HM; Bubniak Ldos S; de Moraes AC; Gaspar PC; Andrade Eda S; Nunes RJ; Santos-Silva MC Chem Res Toxicol; 2013 Dec; 26(12):1904-16. PubMed ID: 24304350 [TBL] [Abstract][Full Text] [Related]
55. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands. Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity. McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and cytotoxicity of (+/-)-7,9-dideoxy-pancratistatin analogues. Nieto-García O; Alonso R Org Biomol Chem; 2013 Jan; 11(3):515-22. PubMed ID: 23207545 [TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, cytotoxicities and DNA cleavage activities of dibenzoxepine and isoquinoline derivatives starting from dehydroabietylamine. Liu CX; Lin ZX; Zhou AM J Asian Nat Prod Res; 2016 Dec; 18(12):1169-1177. PubMed ID: 27696913 [TBL] [Abstract][Full Text] [Related]
59. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage. De Isabella P; Zunino F; Capranico G Nucleic Acids Res; 1995 Jan; 23(2):223-9. PubMed ID: 7862525 [TBL] [Abstract][Full Text] [Related]
60. Synthesis and cytotoxic activity of pyrazino[1,2-b]-isoquinolines, 1-(3-isoquinolyl)isoquinolines, and 6,15-iminoisoquino[3,2-b]-3-benzazocines. González JF; de la Cuesta E; Avendaño C Bioorg Med Chem; 2007 Jan; 15(1):112-8. PubMed ID: 17070059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]